333 related articles for article (PubMed ID: 11686868)
1. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease.
Greenfeder S; Umland SP; Cuss FM; Chapman RW; Egan RW
Respir Res; 2001; 2(2):71-9. PubMed ID: 11686868
[TBL] [Abstract][Full Text] [Related]
2. The roles of IL-5 and anti-IL-5 treatment in eosinophilic diseases: Asthma, eosinophilic granulomatosis with polyangiitis, and eosinophilic chronic rhinosinusitis.
Nagase H; Ueki S; Fujieda S
Allergol Int; 2020 Apr; 69(2):178-186. PubMed ID: 32139163
[TBL] [Abstract][Full Text] [Related]
3. [Eosinophilia and interleukin-5: role in pulmonary atopic processes].
Druilhe A; Pretolani M
Med Trop (Mars); 1998; 58(4 Suppl):437-43. PubMed ID: 10410362
[TBL] [Abstract][Full Text] [Related]
4. [Role of eosinophilia in atopic pathology].
Magnan A; Vervloet D
Med Trop (Mars); 1998; 58(4 Suppl):444-6. PubMed ID: 10410363
[TBL] [Abstract][Full Text] [Related]
5. Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.
Gavett SH; O'Hearn DJ; Li X; Huang SK; Finkelman FD; Wills-Karp M
J Exp Med; 1995 Nov; 182(5):1527-36. PubMed ID: 7595222
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-5 pathway inhibition in the treatment of eosinophilic respiratory disorders: evidence and unmet needs.
Varricchi G; Bagnasco D; Borriello F; Heffler E; Canonica GW
Curr Opin Allergy Clin Immunol; 2016 Apr; 16(2):186-200. PubMed ID: 26859368
[TBL] [Abstract][Full Text] [Related]
7. TH2 cytokine expression in bronchoalveolar lavage fluid T lymphocytes and bronchial submucosa is a feature of asthma and eosinophilic bronchitis.
Brightling CE; Symon FA; Birring SS; Bradding P; Pavord ID; Wardlaw AJ
J Allergy Clin Immunol; 2002 Dec; 110(6):899-905. PubMed ID: 12464957
[TBL] [Abstract][Full Text] [Related]
8. Eosinophils in asthma and other allergic diseases.
Wardlaw AJ; Brightling C; Green R; Woltmann G; Pavord I
Br Med Bull; 2000; 56(4):985-1003. PubMed ID: 11359633
[TBL] [Abstract][Full Text] [Related]
9. Anti-IL-5 monoclonal antibody inhibits allergic late phase bronchial eosinophilia in guinea pigs: a therapeutic approach.
Chand N; Harrison JE; Rooney S; Pillar J; Jakubicki R; Nolan K; Diamantis W; Sofia RD
Eur J Pharmacol; 1992 Jan; 211(1):121-3. PubMed ID: 1618260
[TBL] [Abstract][Full Text] [Related]
10. Th2-induced airway mucus production is dependent on IL-4Ralpha, but not on eosinophils.
Cohn L; Homer RJ; MacLeod H; Mohrs M; Brombacher F; Bottomly K
J Immunol; 1999 May; 162(10):6178-83. PubMed ID: 10229862
[TBL] [Abstract][Full Text] [Related]
11. Benralizumab: From the Basic Mechanism of Action to the Potential Use in the Biological Therapy of Severe Eosinophilic Asthma.
Pelaia C; Calabrese C; Vatrella A; Busceti MT; Garofalo E; Lombardo N; Terracciano R; Pelaia G
Biomed Res Int; 2018; 2018():4839230. PubMed ID: 29862274
[TBL] [Abstract][Full Text] [Related]
12. Th-2 cytokines in allergic disease.
Robinson DS
Br Med Bull; 2000; 56(4):956-68. PubMed ID: 11359631
[No Abstract] [Full Text] [Related]
13. Pharmacokinetic/pharmacodynamic profile of reslizumab in asthma.
Matera MG; Rogliani P; Calzetta L; Cazzola M
Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):239-245. PubMed ID: 29268638
[TBL] [Abstract][Full Text] [Related]
14. Interplay Between the IL-33/ST2 Axis and Bone Marrow ILC2s in Protease Allergen-Induced IL-5-Dependent Eosinophilia.
Boberg E; Johansson K; Malmhäll C; Calvén J; Weidner J; Rådinger M
Front Immunol; 2020; 11():1058. PubMed ID: 32582171
[No Abstract] [Full Text] [Related]
15. Eosinophilopoiesis in a murine model of allergic airway eosinophilia: involvement of bone marrow IL-5 and IL-5 receptor alpha.
Tomaki M; Zhao LL; Lundahl J; Sjöstrand M; Jordana M; Lindén A; O'Byrne P; Lötvall J
J Immunol; 2000 Oct; 165(7):4040-50. PubMed ID: 11034415
[TBL] [Abstract][Full Text] [Related]
16. The neutralization of interleukin-5 as a therapeutic concept in allergic inflammation.
Simon HU
Sarcoidosis Vasc Diffuse Lung Dis; 2002 Mar; 19(1):25-8. PubMed ID: 12002381
[TBL] [Abstract][Full Text] [Related]
17. Anti-interleukin-5 antibody therapy in eosinophilic diseases.
Simon D; Braathen LR; Simon HU
Pathobiology; 2005; 72(6):287-92. PubMed ID: 16582580
[TBL] [Abstract][Full Text] [Related]
18. A role for eosinophils in transplant rejection.
Goldman M; Le Moine A; Braun M; Flamand V; Abramowicz D
Trends Immunol; 2001 May; 22(5):247-51. PubMed ID: 11323281
[TBL] [Abstract][Full Text] [Related]
19. Mepolizumab in the management of severe eosinophilic asthma in adults: current evidence and practical experience.
Varricchi G; Bagnasco D; Ferrando M; Puggioni F; Passalacqua G; Canonica GW
Ther Adv Respir Dis; 2017 Jan; 11(1):40-45. PubMed ID: 27856823
[TBL] [Abstract][Full Text] [Related]
20. Monoclonal antibody therapy for the treatment of asthma and chronic obstructive pulmonary disease with eosinophilic inflammation.
Nixon J; Newbold P; Mustelin T; Anderson GP; Kolbeck R
Pharmacol Ther; 2017 Jan; 169():57-77. PubMed ID: 27773786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
